Rong Wang

Novel exosome-targeted T-cell-based vaccine counteracts T-cell anergy and converts CTL exhaustion in chronic infection via CD40L signaling through the mTORC1 pathway

J. Xiang, Xueying Zhang, A. Freywald, 2016, Cellular &Molecular Immunology.

Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44+CD62Lhigh IL-7R+ CTLs with up- and downregulation of anti- and pro-apoptosis genes

J. Xiang, A. Freywald, Yue Chen, 2014, Cellular and Molecular Immunology.

HIV-1 Gag-specific exosome-targeted T cell-based vaccine stimulates effector CTL responses leading to therapeutic and long-term immunity against Gag/HLA-A2-expressing B16 melanoma in transgenic HLA-A2 mice

J. Xiang, Jianqing Xu, Yufeng Xie, 2014 .

CD40 agonist converting CTL exhaustion via the activation of the mTORC1 pathway enhances PD-1 antagonist action in rescuing exhausted CTLs in chronic infection.

J. Xiang, A. Freywald, C. Zheng, 2017, Biochemical and biophysical research communications.

Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.

J. Xiang, Yufeng Xie, C. S. Umeshappa, 2012, Vaccine.

Novel HIV-1 Gag-specific Exosome-targeted CD8+ T cell-Based Therapeutic Vaccine Capable of Converting CTL Exhaustion in Chronic Infection

Rong Wang, 2015 .

GP120-specific exosome-targeted T cell-based vaccine capable of stimulating DC- and CD4(+) T-independent CTL responses.

J. Xiang, R. Chibbar, Yangdou Wei, 2011, Vaccine.

The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity.

Rong Wang, R. F. Wang, 2001, Trends in immunology.